Further analysis revealed that among individuals with aMCI due to AD, KL-VSHET carriers were 48% less likely to be diagnosed with AD dementia, with a similar trend observed in both APOE ε4 carriers and non-carriers. This evidence concerns the gene APOE and Alzheimer disease.